12:00 AM
 | 
Aug 28, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

ThGRF 1-44: Phase II trial update

Theratechnologies Inc. (TSE:TH), Saint Laurent, Quebec
Product: ThGRF 1-44
Business: Metabolic
Therapeutic category: Hormone replacement
Target: Growth hormone...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >